CD13 facilitates immune cell migration and aggravates acute injury but promotes chronic post-stroke recovery

Abstract Introduction Acute stroke leads to the activation of myeloid cells. These cells express adhesion molecules and transmigrate to the brain, thereby aggravating injury. Chronically after stroke, repair processes, including angiogenesis, are activated and enhance post-stroke recovery. Activated...

Full description

Bibliographic Details
Published in:	Journal of Neuroinflammation
Main Authors:	Justin N. Nguyen, Eric C. Mohan, Gargee Pandya, Uzma Ali, Chunfeng Tan, Julia K. Kofler, Linda Shapiro, Sean P. Marrelli, Anjali Chauhan
Format:	Article
Language:	English
Published:	BMC 2023-10-01
Subjects:	CD13 Ischemic stroke Stroke recovery Cognitive impairment CXCL12 CXCR4
Online Access:	https://doi.org/10.1186/s12974-023-02918-3

Similar Items

Correlations Between Serum CXCL9/12 and the Severity of Acute Ischemic Stroke, a Retrospective Observational Study
by: Han M, et al.
Published: (2023-01-01)

Interactions of the chemokines CXCL11 and CXCL12 in human tumor cells
by: Christian Koch, et al.
Published: (2022-12-01)

Mesenteric Lymphatic B Cells Migrate to the Intestine and Aggravate DSS-Induced Colitis via the CXCR5–CXCL13 Axis
by: Yu Zhang, et al.
Published: (2024-05-01)

The CXCL12/CXCR4 Axis: An Emerging Therapeutic Target for Chronic Pain
by: Chen Z, et al.
Published: (2025-05-01)

The effect of CXCL12 on survival outcomes of patients with viral hepatitis-associated hepatocellular carcinoma after hepatectomy
by: Yan Lu, et al.
Published: (2024-05-01)

Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells
by: Heinrich Eileen L, et al.
Published: (2012-04-01)

CXCL13 and Its Receptor CXCR5 in Cancer: Inflammation, Immune Response, and Beyond
by: Marcelo G. Kazanietz, et al.
Published: (2019-07-01)

High expression of CXCL13 predicts a favorable response to immunotherapy by upregulating CXCR5+CD8+ T-cell infiltration in gastric cancer
by: Shuning Xu, et al.
Published: (2025-05-01)

The Role of CXCL13 in Antibody Responses to HIV-1 Infection and Vaccination
by: Yonas Bekele Feyissa, et al.
Published: (2021-02-01)

The role of CXCL12/CXCR4/CXCR7 axis in cognitive impairment associated with neurodegenerative diseases
by: Rojin Sarallah, et al.
Published: (2025-02-01)

CXCL12 and CXCR4 as Novel Biomarkers in Uric Acid-Induced Inflammation and Patients with Gouty Arthritis
by: Seong-Kyu Kim, et al.
Published: (2023-02-01)

IS4‐FAM, a fluorescent tool to study CXCR4 affinity and competitive antagonism in native cancer cells
by: Isabel Hamshaw, et al.
Published: (2024-10-01)

Glia Cells Control Olfactory Neurogenesis by Fine-Tuning CXCL12
by: André Dietz, et al.
Published: (2023-08-01)

The role of CXCR3 and its ligands in cancer
by: Xiaoming Wang, et al.
Published: (2022-11-01)

Research progress on the regulation of autophagy in cardiovascular diseases by chemokines
by: Ma Jingfeng, et al.
Published: (2025-06-01)

The utility of CXCL13 and circulating CXCR5+ T cell detection in the diagnosis of systemic lupus erythematosus associated nephritis
by: Yu Liu, et al.
Published: (2025-10-01)

Involvement of chemokine CXCL12 and its receptor CXCR4 in uterine receptivity and potential relationship to fertility in cattle: a mini review
by: Michael J. D’Occhio, et al.
Published: (2025-08-01)

云芝多糖-B对人食管癌细胞Eca109转移的影响
Published: (2013-01-01)

Extracellular Hsp70 Is Involved in the CXCL12/CXCR4 Pathway in Primary Human Nasal Epithelial Cells: A Preliminary Study
by: Seong Hee Kim, et al.
Published: (2023-11-01)

Association of CXCL12 and CXCR4 Genes Polymorphism with Proliferative Diabetic Retinopathy in Diabetic Patients
by: Saba Gharibi, et al.
Published: (2022-10-01)

Mesenchymal stem cells from bone marrow regulate invasion and drug resistance of multiple myeloma cells by secreting chemokine CXCL13
by: Guihua Zhang, et al.
Published: (2020-05-01)

Revisiting the Role of the CXCL13/CXCR5-Associated Immune Axis in Melanoma: Potential Implications for Anti-PD-1-Related Biomarker Research
by: Magdalena Hoellwerth, et al.
Published: (2023-02-01)

LncRNA MALAT1 silencing represses CXCL12-induced proliferation, invasion, and homing behavior in multiple myeloma by inhibiting CXCR4
by: Jing Ning, et al.
Published: (2024-12-01)

Correction: Mechanism underlying the involvement of CXCR4/CXCL12 in diabetic wound healing and prospects for responsive hydrogel-loaded CXCR4 formulations
by: Lingli Wang, et al.
Published: (2025-07-01)

Mechanism underlying the involvement of CXCR4/CXCL12 in diabetic wound healing and prospects for responsive hydrogel-loaded CXCR4 formulations
by: Lingli Wang, et al.
Published: (2025-04-01)

The importance of CXCR4 expression in tumor stroma as a potential biomarker in pancreatic cancer
by: Raquel Bodoque-Villar, et al.
Published: (2023-09-01)

CXCR4-Targeted Radiopharmaceuticals for the Imaging and Therapy of Malignant Tumors
by: Jingjing Yu, et al.
Published: (2023-06-01)

CXCL12/CXCR4/CXCR7 axis in placenta tissues of patients with placenta previa
by: Wu Xia, et al.
Published: (2023-08-01)

Intrauterine adhesions repair with menstrual blood-derived mesenchymal stem cells via CXCL13-CXCR5 signal axis and its mechanism
by: Bing Luo, et al.
Published: (2024-10-01)

Expression and regulation of the CXCL9-11 chemokines and CXCR3 receptor in Atlantic salmon (Salmo salar)
by: Natalia Valdés, et al.
Published: (2024-09-01)

The Distinct Roles of CXCR3 Variants and Their Ligands in the Tumor Microenvironment
by: Nathan Reynders, et al.
Published: (2019-06-01)

CXCL12α/SDF‐1 from perisynaptic Schwann cells promotes regeneration of injured motor axon terminals
by: Samuele Negro, et al.
Published: (2017-05-01)

Targeting the CXCR4/CXCL12 Axis in Cancer Therapy: Analysis of Recent Advances in the Development of Potential Anticancer Agents
by: Gerardina Smaldone, et al.
Published: (2025-03-01)

CXCL12/CXCR4 modulates macrophage efferocytosis to induce glomerular crescent formation and fibrosis via ELMO1/DOCK180/RAC1 signaling in ANCA-associated glomerulonephritis
by: Zilin Liu, et al.
Published: (2025-07-01)

A1, an innovative fluorinated CXCR4 inhibitor, redefines the therapeutic landscape in colorectal cancer
by: Hossein Khorramdelazad, et al.
Published: (2025-01-01)

Regulation of Neurogenesis in Mouse Brain by HMGB1
by: Xiang Zhao, et al.
Published: (2020-07-01)

CXCL12-loaded-hydrogel (CLG): A new device for metastatic circulating tumor cells (CTCs) capturing and characterization
by: Luigi Portella, et al.
Published: (2024-08-01)

CXCL12 and CXCR4 as Potential Early Biomarkers for Luminal A and Luminal B Subtypes of Breast Cancer
by: Motyka J, et al.
Published: (2023-07-01)

SDF-1/CXCL12 and CXCR4 gene variants, and elevated serum SDF-1 levels are associated with preeclampsia
by: Savas Karakus, et al.
Published: (2017-04-01)

Clinical and prognostic relevance of CXCL12 expression in acute myeloid leukemia
by: Shi-sen Wang, et al.
Published: (2021-07-01)